Altitude Life Science Ventures is a venture capital firm in Colorado that focuses on life science markets with strong demand and growth potential. Founded 2006 in Durango, Colorado, United States by Steve Johnson and Dave Maki, it invests in early stage ventures and late stage ventures. Its portfolio companies include Omniome, Nuvation Bio, Encoded Therapeutics, Inc., BlackThorn Therapeutics, Vividion Therapeutics, Beam Therapeutics, Millendo Therapeutics, Omniome, UNITY Biotechnology, and Effector Therapeutics. As of March 2020, Altitude Life Science Ventures has made 31 investments. Their most recent investment was on January 9, 2020, when Omniome raised $60M. Altitude Life Science Ventures has had eight exits, the most notable of which include Vir Biotechnology, UNITY Biotechnology, and Receptos. The company has raised a single venture fund, Altitude Life Science Ventures Fund III.
A biotechnology company developing drugs and treatments to diminish negative health effects associated with aging.
A synthetic biology company using CRISPR to develop a portfolio of genetic medicines.
A biopharmaceutical company developing neurobehavioural therapeutic treatments using artificial intelligence and clinical neuroscience.
A biopharmaceutical company dedicated to the development of novel therapeutics in the field of Epigenetics
Encoded Therapeutics is a developer of genomics-driven precision medicine targeting and treating genetic diseases and disorders.
Omniome is a San Diego-based company.
A company that focuses on discovery and development of prescription aesthetic medicine
DiCE Molecules is a Redwood City, California-based company.
A company developing pharmaceutical products with attenuated tissue specific toxicity
Documentaries, videos and podcasts
Encoded Therapeutics, Inc.